News

Brokerages Achieve Profitability in 2025 through Cost Management

Brokerages Achieve Profitability in 2025 through Cost Management

Brokerages Show Signs of Recovery in Profitability

In recent research released by AccountTECH, real estate brokerages exhibited notable improvements in profitability during 2025. The findings suggest that expense reductions played a pivotal role, as firms managed to return to profitability despite a challenging environment. This research analyzed data from 157 brokerage firms, highlighting that many are opting for cost-cutting measures instead of relying on sales growth.

Understanding Profitability Metrics

The study particularly focused on median EBITDA margins—an essential measure of profitability that considers earnings before interest, taxes, depreciation, and amortization. By assessing profitability as a percentage of income, AccountTECH created an equitable framework for comparing businesses of varying sizes. Interestingly, while profit margins slightly improved over the previous year, they are still significantly lower than those observed earlier in the decade.

Trends in Profitability

AccountTECH characterized 2025 as the year of the "efficiency wedge," noting that many brokerages regained profitability despite stagnant sales and a decreasing number of agents. The study concluded that traditional metrics such as increased transaction volumes and a rise in agent counts were absent. Even though the sales volume showed little change, agent numbers dwindled, causing upward pressure on sales costs—the first increase in many years.

Increasing Profitability Among Brokerages

In 2025, the median EBITDA margin increased to 1.68 percent, a rise from 1.35 percent in 2024. This incline indicates a positive trend, with approximately 70 percent of the examined brokerages achieving profitability—a considerable rise from about 61 percent the previous year. This marks a significant improvement compared to 2023, when less than 57 percent of firms reported profits.

Improved Margins for Unprofitable Firms

Unprofitable firms also showed considerable improvements. Their median margins improved from -1.87 percent in 2024 to -1.39 percent in 2025. These improvements contributed substantially to the overall recovery of the EBITDA margin. Meanwhile, those brokerages already operating at a profit saw less dramatic gains, with their median margins rising from 3.22 percent to 3.37 percent—still below historical highs.

Cost Management as a Key Driver

The research by AccountTECH emphasizes that the improvements in 2025 stemmed primarily from rigorous expense management rather than increased sales revenues. Although sales costs climbed, resulting in a decline in gross profit margins from 19.07 percent to 18.14 percent, significant drops in operating expenses enabled overall stability in profitability metrics.

Identifying Expense-Reduction Trends

Operating expenses fell noticeably, decreasing from 17.52 percent in 2024 to 16.39 percent of income in 2025. This substantial reduction was achieved across various categories, with the most considerable savings coming from non-labor operational costs.

A Comprehensive Five-Year Perspective

In reviewing five years of industry data, AccountTECH observed a notable trend: from 2021 to 2023, rising operating expenses largely contributed to declining profitability. On the contrary, in 2024 and 2025, significant improvements in profitability were attributed to tighter expense management, even amid the increase in sales costs.

Industry Insights from Leadership

Mark Blagden, CEO of AccountTECH, pointed out that the 2025 data reinforces the experiences of brokerage leaders, indicating stability in profit margins but highlighting an uneven recovery. He noted that a key takeaway this year was not the attainment of higher profits but the reduction in the number of firms operating at a loss, along with decreasing losses among those that remained unprofitable.

Importance of Financial Transparency

AccountTECH's study underscores the significance of clear financial reporting in helping leaders within the brokerage sector pinpoint areas of improvement and ongoing financial pressures, particularly in times of tight margins.

About AccountTECH

AccountTECH specializes in providing advanced accounting systems, financial intelligence, and benchmarking services tailored for real estate brokerages. The company serves numerous offices throughout North America and Canada, delivering insights that empower brokerage leaders to enhance their operational performance. For additional information regarding the research or inquiries related to brokerage performance, please reach out to AccountTECH.

Frequently Asked Questions

What factors contributed to improving profitability for brokerages in 2025?

The improvement in profitability for brokerages in 2025 mainly came from significant expense reductions rather than an increase in sales revenues.

How did AccountTECH measure profitability?

AccountTECH measured profitability through median EBITDA margins, which reflect earnings before interest, taxes, depreciation, and amortization as a percentage of income.

Was there an increase in the number of profitable brokerages?

Yes, approximately 70 percent of brokerages were profitable in 2025, up from roughly 61 percent the previous year.

Did all brokerages experience the same level of profitability improvement?

No, while a significant number of brokerages improved profitability, firms already profitable saw modest gains compared to those that were unprofitable, which experienced dramatic improvement.

What does the future hold for brokerage firms based on the research findings?

The research suggests a gradual recovery for brokerage firms but emphasizes that returning to the higher profit margins of previous market cycles remains unlikely in the short term.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading